ARCHIVES

FDA Proposes To Drop Specific Requirements For Reprint Distribution On Off-Label Uses.

This article is from The Cancer Letter archive.

Vol. 34 No. 07 | February 22, 2008

Download PDF Visit The Full Archive

Related Articles

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

Army Plans Solicitation For Breast Cancer Research Proposals

April 21, 1995

Six Centers Win Grants

July 11, 2003

Congress Ignores construction Fund Reprogramming

February 18, 1977

Chemical Industry Sues NTP Over Listing PDC As Carcinogen; Environmental Groups Join Defense

June 23, 1989

“Evolving Concept” Looks At Appropriate Early Decision Making In Patient Management

September 28, 1984